Literature DB >> 12960281

Phosphatidylinositol 3-kinase is essential for kit ligand-mediated survival, whereas interleukin-3 and flt3 ligand induce expression of antiapoptotic Bcl-2 family genes.

Richard Karlsson1, Maria Engström, Maria Jönsson, Peter Karlberg, Cornelis J H Pronk, Johan Richter, Jan-Ingvar Jönsson.   

Abstract

Cytokines such as interleukin 3 (IL-3), kit ligand (KL), and flt3 ligand (FL) promote survival of hematopoietic stem cells and myeloid progenitor cells. In many cell types, members of the Bcl-2 gene family are major regulators of survival, but the mediating mechanisms are not fully understood. Using two myeloid progenitor cell lines, FDCP-mix and FDC-P1, as well as primary mouse bone marrow progenitors, we demonstrate that KL-mediated survival is dependent on the activation of phosphatidylinositol-3 (PI-3) kinase. The inhibitor LY294002 was able to completely abolish survival mediated by KL, whereas IL-3 and FL were only partially affected. Although all three cytokines induced phosphorylation of protein kinase B (PKB), only KL required PI-3 kinase activity to elicit survival in hematopoietic progenitors. In contrast, pretreatment of cells with inhibitors to the MAP kinase pathway did not affect the survival. We next established if IL-3 and FL activated antiapoptotic Bcl-2 and the related genes Bcl-XL and Mcl-1. By RNA protection assay and Western blot analysis, we show that all three genes are induced by IL-3, whereas FL induces Bcl-2 and to some extent Bcl-XL. Importantly, KL could not sustain their expression. Moreover, use of inhibitors implied that IL-3 was mainly exerting its effect on Bcl-2 at the level of transcription. The addition of LY294002 did not affect the expression of Bcl-2 and Bcl-XL, and thus, we conclude that expression of antiapoptotic Bcl-2 family member genes is not dependent on PI-3 kinase activity. Our results indicate that cytokines exert distinct survival effects and that FL and IL-3 are capable of sustaining progenitor survival by up-regulating the expression of Bcl-2 and related genes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12960281     DOI: 10.1189/jlb.0403142

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  5 in total

1.  Transforming growth factor-{beta}1 modulates responses of CD34+ cord blood cells to stromal cell-derived factor-1/CXCL12.

Authors:  Sunanda Basu; Hal E Broxmeyer
Journal:  Blood       Date:  2005-03-29       Impact factor: 22.113

2.  Mitf dosage as a primary determinant of melanocyte survival after ultraviolet irradiation.

Authors:  Thomas J Hornyak; Shunlin Jiang; Esther A Guzmán; Beth N Scissors; Chinisada Tuchinda; Hongbin He; James D Neville; Faith M Strickland
Journal:  Pigment Cell Melanoma Res       Date:  2009-02-03       Impact factor: 4.693

3.  TNF-α/Fas-RIP-1-induced cell death signaling separates murine hematopoietic stem cells/progenitors into 2 distinct populations.

Authors:  Yechen Xiao; Hongling Li; Jun Zhang; Andrew Volk; Shubin Zhang; Wei Wei; Shanshan Zhang; Peter Breslin; Jiwang Zhang
Journal:  Blood       Date:  2011-10-11       Impact factor: 25.476

Review 4.  Cardiac Mast Cells: A Two-Head Regulator in Cardiac Homeostasis and Pathogenesis Following Injury.

Authors:  Jing Jin; Yuanyuan Jiang; Subrata Chakrabarti; Zhaoliang Su
Journal:  Front Immunol       Date:  2022-07-15       Impact factor: 8.786

5.  Bcl11b mutations identified in murine lymphomas increase the proliferation rate of hematopoietic progenitor cells.

Authors:  Anneli Karlsson; Amanda Nordigården; Jan-Ingvar Jönsson; Peter Söderkvist
Journal:  BMC Cancer       Date:  2007-10-17       Impact factor: 4.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.